IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGLIONE DI MONALE E BASTIA, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.360
AS - Asia 4.933
EU - Europa 4.528
SA - Sud America 944
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
Totale 21.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.186
SG - Singapore 1.693
CN - Cina 1.673
UA - Ucraina 1.005
BR - Brasile 820
DE - Germania 797
IT - Italia 651
HK - Hong Kong 646
PL - Polonia 612
FI - Finlandia 340
GB - Regno Unito 267
VN - Vietnam 264
RU - Federazione Russa 249
TR - Turchia 227
IE - Irlanda 188
FR - Francia 167
IN - India 130
CA - Canada 88
BD - Bangladesh 57
MX - Messico 52
ZA - Sudafrica 49
AR - Argentina 48
SE - Svezia 46
ID - Indonesia 42
CZ - Repubblica Ceca 41
IQ - Iraq 35
JP - Giappone 31
ES - Italia 28
NL - Olanda 28
EC - Ecuador 25
AT - Austria 21
UZ - Uzbekistan 20
BE - Belgio 19
PK - Pakistan 17
MA - Marocco 15
SA - Arabia Saudita 15
CO - Colombia 14
EU - Europa 14
VE - Venezuela 14
LT - Lituania 13
AU - Australia 12
IR - Iran 10
GR - Grecia 9
PY - Paraguay 8
TN - Tunisia 8
BY - Bielorussia 7
IL - Israele 7
JO - Giordania 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
JM - Giamaica 6
KG - Kirghizistan 6
MY - Malesia 6
OM - Oman 6
PA - Panama 6
AL - Albania 5
CH - Svizzera 5
EG - Egitto 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
DK - Danimarca 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
MU - Mauritius 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
IS - Islanda 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SL - Sierra Leone 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
LU - Lussemburgo 1
Totale 21.885
Salva come PNG Salva come JPEG
Città #
Fairfield 1.304
Ashburn 1.119
Woodbridge 1.085
Singapore 843
Jacksonville 727
Houston 691
Hong Kong 641
Warsaw 602
Seattle 571
Cambridge 540
Chandler 535
Ann Arbor 495
Wilmington 472
Beijing 404
New York 339
Princeton 337
Los Angeles 219
Nanjing 211
Dublin 187
Helsinki 183
Dearborn 178
Istanbul 173
The Dalles 161
Munich 145
Dallas 120
Brescia 108
Nanchang 91
Shanghai 90
Buffalo 88
Des Moines 88
São Paulo 84
Moscow 83
Ho Chi Minh City 80
San Francisco 76
Milan 75
San Diego 71
Changsha 61
Dong Ket 52
Shenyang 51
Jinan 50
Hebei 49
Tianjin 48
Turku 47
Redondo Beach 46
Chicago 45
London 45
Washington 45
Boardman 42
Hanoi 40
Santa Clara 38
Jiaxing 37
Kunming 34
Montreal 31
Denver 30
Nuremberg 30
Johannesburg 29
Orem 29
Brooklyn 28
Hangzhou 28
Jakarta 28
Poplar 28
Tokyo 28
Toronto 28
Rio de Janeiro 27
Brno 26
Chennai 25
Lancaster 25
Zhengzhou 23
Ningbo 21
Phoenix 21
Mexico City 20
Brussels 19
Brasília 18
Kocaeli 18
Stockholm 18
Tashkent 18
Guangzhou 17
Atlanta 16
Ceto 16
Haikou 16
Rome 16
Taizhou 16
Ankara 15
Boston 15
Nürnberg 15
Verona 15
Baronissi 14
Dhaka 14
Frankfurt am Main 14
Lanzhou 14
Quito 14
Manchester 13
Norwalk 13
Changchun 12
Charlotte 12
Curitiba 12
Pune 12
Redwood City 12
Romola 12
Amsterdam 11
Totale 14.878
Salva come PNG Salva come JPEG
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 256
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 254
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 242
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 236
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 233
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 210
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 208
Pros-IT CNR: an Italian prostate cancer monitoring project 206
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 195
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 192
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 188
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 186
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 184
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 179
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 178
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 177
Radiotherapy in patients with HIV: current issues and review of the literature 176
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 176
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 173
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 170
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 168
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 166
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 166
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 162
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 162
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 162
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 160
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 159
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 158
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 158
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 158
Role of external beam radiotherapy in the treatment of relapsing meningioma 157
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 157
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 157
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 155
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 154
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 151
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 150
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 150
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 149
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 149
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 148
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 147
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 146
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 146
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 145
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 144
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 144
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 144
From Molecular to Clinical Radiation Biology of Glioblastoma 143
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 142
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 141
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 140
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 139
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 139
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 139
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 138
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 136
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 135
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 134
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 134
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 134
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 134
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 133
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 133
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 132
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 131
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 130
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 130
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 130
Information Retrieval in Medicine: an Extensive Experimental Study 129
Cetuximab and Radiation Therapy in Head and Neck Cancer 129
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 127
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 127
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 126
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 125
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 125
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 125
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 122
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 122
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 120
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 119
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 119
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 119
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 119
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 118
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 118
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 118
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 117
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 117
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 116
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 116
Comparison of toxicity in patients treated with conformal external radiotherapy and brachitherapy for prostate cancer. 115
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 115
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 114
Nasopharyngeal carcinoma 114
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 114
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 114
Totale 15.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.957 0 0 0 0 0 357 113 316 320 394 262 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20253.375 31 41 29 491 333 300 285 139 317 286 725 398
2025/20264.166 680 915 493 936 762 380 0 0 0 0 0 0
Totale 22.302